Patients with peripheral T-cell lymphoma, not otherwise specified, most commonly have a CD4+/CD8- phenotype, with only a few being CD4/CD8 +/+ or −/−, demonstrating the potential of anti-CD4 CAR-T cells [65]. The gene discussed is CD8A; the disease is peripheral T-cell lymphoma, not otherwise specified.